SCHEMBL1733025

SCHEMBL1733025

COc1cc(NC(=O)CCCc2ccc(NC(=O)Nc3ccccc3)cc2)c(C(C)=O)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.59
NPC1 O15118 3/20 0.59
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 3/20 0.58
NPSR1 Q6W5P4 2/20 0.58
HSD17B10 Q99714 2/20 0.58
HPGD P15428 1/20 0.58
RCE1 Q9Y256 1/20 0.58
POLB P06746 2/20 0.54
HDAC3 O15379 2/20 0.51
HDAC4 P56524 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC7 Q8WUI4 2/20 0.51
HDAC2 Q92769 2/20 0.51
HDAC10 Q969S8 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC8 Q9BY41 2/20 0.51
HDAC6 Q9UBN7 2/20 0.51
HDAC9 Q9UKV0 2/20 0.51
HDAC5 Q9UQL6 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1732760 0.94 KDM4E (0.60) RAB9ANPC1KDM4EALDH1A1NPSR1
SCHEMBL7485820 0.87 KDM4E (0.57) RAB9ANPC1KDM4EALDH1A1POLB
SCHEMBL1732832 0.87 KDM4E (0.62) RAB9AKDM4EALDH1A1NPSR1HSD17B10
SCHEMBL1732450 0.85 LMNA (0.51) RAB9AKDM4EALDH1A1NPSR1HSD17B10
SCHEMBL1732263 0.85 EPHX2 (0.53) RAB9ANPC1KDM4EALDH1A1NPSR1
SCHEMBL1733491 0.85 KDM4E (0.61) RAB9ANPC1KDM4EALDH1A1NPSR1
SCHEMBL1733226 0.85 KDM4E (0.51) RAB9ANPC1KDM4EALDH1A1NPSR1
SCHEMBL7476170 0.84 KDM4E (0.59) RAB9ANPC1KDM4EALDH1A1NPSR1
SCHEMBL1733753 0.84 KDM4E (0.48) KDM4EALDH1A1NPSR1HSD17B10HPGD
SCHEMBL1732409 0.84 ABCB1 (0.50) KDM4EALDH1A1NPSR1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9066912-B2 Drug-enhanced adhesion prevention ETHICON, INC. (US) 2015-06-30 US claimed
EP-2035008-B1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON INC (US) 2011-11-23 EP claimed
EP-1732486-A4 DRUG-ENHANCED ADHESION PREVENTION ETHICON INC (US) 2009-04-08 EP claimed
EP-2035008-A2 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS Ethicon, Incorporated (US) 2009-03-18 EP claimed
WO-2007146920-A2 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON, INC. (US) 2007-12-21 WO claimed
US-20070286892-A1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON, INC. 2007-12-13 US claimed
JP-2007528391-A 2007-10-11 JP claimed
EP-1732486-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2006-12-20 EP claimed
WO-2005092264-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2005-10-06 WO claimed
US-20050106229-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US claimed
US-20050106230-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US claimed
US-9066912-B2 Drug-enhanced adhesion prevention ETHICON, INC. (US) 2015-06-30 US disclosed
EP-1732486-B1 TRANILAST COMPOSITION FOR USE IN THE PREVENTION OF POSTOPERATIVE ADHESION ETHICON INC (US) 2014-05-07 EP disclosed
EP-2035008-B1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON INC (US) 2011-11-23 EP disclosed
EP-2335703-A1 Compositions and Methods for Preventing or Reducing Postoperative Ileus and Gastric Stasis in Mammals Ethicon, Incorporated (US) 2011-06-22 EP disclosed
EP-1732486-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2006-12-20 EP disclosed
WO-2005092264-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2005-10-06 WO disclosed
US-20050106230-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US disclosed
US-20050106229-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US disclosed
EP-1229010-A1 NOVEL DIARYLAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES Japan Energy Corporation (JP) 2002-08-07 EP disclosed